HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ)
$37.95 1.12 (3.041%)
Analysed HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) News Sources
HRMY vs. CSLLY: Which Stock Is the Better Value Option?
06-10-2026
yahoo.com
Harmony BioSciences' Wakix Franchise, Pipeline Offer Multiple Value Drivers, Oppenheimer Says
08-10-2026
yahoo.com
Harmony Biosciences (HRMY) Stock Looks Below Fair Value As Shares Rose 48%
08-10-2026
yahoo.com
Harmony Biosciences (HRMY) Heads To European Narcolepsy Days With New Phase 3 Data
08-10-2026
yahoo.com
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
12-10-2026
yahoo.com
Why Harmony Biosciences Stock Got Mashed on Monday
12-10-2026
fool.com
HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?
16-10-2026
yahoo.com
Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
20-10-2026
yahoo.com
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
22-10-2026
yahoo.com
HRMY or ARGX: Which Is the Better Value Stock Right Now?
22-10-2026
yahoo.com
What is the current price of HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ)?
The current price of HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) is $37.95.
HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) absolute price change since previous trading day?
The absolute price change of HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) since the previous trading day is $1.12.
HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) percentage price change since previous trading day?
The percentage price change of HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) since the previous trading day is 3.041%.
What is the most recent average sentiment score for HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ)?
The most recent average sentiment score for HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ)?
The most recent sentiment for HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ) is .
SEC-8K** Filing Available For HARMONY BIOSCIENCES HOLDINGS (HRMY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.